NVI director defends Siam Bioscience after debate

NVI director defends Siam Bioscience after debate

National Vaccine Institute (NVI) director Nakorn Premsri showed a letter from the AstraZeneca company, issued on Monday, in an attempt to prove that Siam Bioscience has passed the evaluation process of AstraZeneca's audit team.

The audit covered issues relating to anti-bribery, anti-corruption (ABAC), supply chain security measures, human rights and financial health and ensured Siam Bioscience was fit to obtain a licence to produce the Covid-19 vaccine for the region.

"AstraZeneca selected Siam Bioscience for its regional hub to produce the vaccine and the evaluation process was executed in the second quarter of last year. The technology transfer started in October, before the government's purchasing order was placed," he said, adding that it has included an extensive evaluation of Siam Bioscience's technical and manufacturing capacity.

The letter also said that it evaluated over 60 potential partners worldwide and out of those selected 25 to join its global network, including Siam Bioscience. All partners are subject to Current Good Manufacturing Practice (CGMP) regulations and appropriate Quality Systems leading to licensure in their specific supply region, he added.

The move came in response to the opposition MPs's criticism during the ongoing censure debate yesterday which attacked the government over its choice to not to join the global Covax programme. Dr Nakorn insisted Covax doesn't offer good prices and that the majority of vaccines come from AstraZeneca.

Do you like the content of this article?
COMMENT
TRENDING

UK hit by latest rail strikes

Football fans and holidaymakers faced travel woe Saturday as train drivers walked out across the United Kingdom, the latest in a series of industrial strikes amid spiralling inflation.

20:40

TikTok show-off turns out to be a thief, say police

A man showing off bundles of banknotes on TikTok and telling viewers he got the money from his own hard work turned out to be a thief, police say.

20:20

No Häagen-Dazs recall in Thailand - FDA

Certain batches of Häagen-Dazs ice cream products that have been found to be contaminated with traces of a chemical linked to cancer have not been imported into Thailand, Food and Drug Administration (FDA) deputy secretary-general Weerachai Nolwachai said on Saturday.

17:36